192 related articles for article (PubMed ID: 33817237)
1. Lnc-PICSAR contributes to cisplatin resistance by miR-485-5p/REV3L axis in cutaneous squamous cell carcinoma.
Wang D; Zhou X; Yin J; Zhou Y
Open Life Sci; 2020; 15(1):488-500. PubMed ID: 33817237
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis.
Lu X; Gan Q; Gan C; Zheng Y; Cai B; Li X; Li D; Yin G
Life Sci; 2021 Jun; 274():118303. PubMed ID: 32841663
[TBL] [Abstract][Full Text] [Related]
3. Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis.
Xie H; Yao J; Wang Y; Ni B
Drug Deliv; 2022 Dec; 29(1):1257-1271. PubMed ID: 35467477
[TBL] [Abstract][Full Text] [Related]
4. Circ_0001402 knockdown suppresses the chemoresistance and development of DDP-resistant cutaneous squamous cell carcinoma cells by functioning as a ceRNA for miR-625-5p.
Li M; Luo M; Liu P; Wang R; Jing H
Exp Dermatol; 2023 Apr; 32(4):529-541. PubMed ID: 36635223
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-573 inhibits cell proliferation, migration and invasion and is downregulated by PICSAR in cutaneous squamous cell carcinoma.
Wang Y; Tang S; Lv J
Bosn J Basic Med Sci; 2022 Apr; 22(2):229-237. PubMed ID: 34905724
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA PRMT5 confers cisplatin-resistance via miR-4458/REV3L axis in non-small-cell lung cancer.
Pang J; Ye L; Zhao D; Zhao D; Chen Q
Cell Biol Int; 2020 Dec; 44(12):2416-2426. PubMed ID: 32808744
[TBL] [Abstract][Full Text] [Related]
7. Exosome-Derived Circ-PVT1 Contributes to Cisplatin Resistance by Regulating Autophagy, Invasion, and Apoptosis Via miR-30a-5p/YAP1 Axis in Gastric Cancer Cells.
Yao W; Guo P; Mu Q; Wang Y
Cancer Biother Radiopharm; 2021 May; 36(4):347-359. PubMed ID: 32799541
[No Abstract] [Full Text] [Related]
8. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X
Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110
[TBL] [Abstract][Full Text] [Related]
9. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis.
Feng N; Guo Z; Wu X; Tian Y; Li Y; Geng Y; Yu Y
Respir Res; 2021 Sep; 22(1):248. PubMed ID: 34537072
[TBL] [Abstract][Full Text] [Related]
10. LncRNA PICSAR promotes cell proliferation, migration and invasion of fibroblast-like synoviocytes by sponging miRNA-4701-5p in rheumatoid arthritis.
Bi X; Guo XH; Mo BY; Wang ML; Luo XQ; Chen YX; Liu F; Olsen N; Pan YF; Zheng SG
EBioMedicine; 2019 Dec; 50():408-420. PubMed ID: 31791845
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA circ-LARP1B contributes to cutaneous squamous cell carcinoma progression by targeting microRNA-515-5p/TPX2 microtubule nucleation factor axis.
Wang L; Hou S; Li J; Tian T; Hu R; Yu N
Bioengineered; 2022 Jan; 13(1):1209-1223. PubMed ID: 34982022
[TBL] [Abstract][Full Text] [Related]
12. Exosome-transferred hsa_circ_0014235 promotes DDP chemoresistance and deteriorates the development of non-small cell lung cancer by mediating the miR-520a-5p/CDK4 pathway.
Xu X; Tao R; Sun L; Ji X
Cancer Cell Int; 2020 Nov; 20(1):552. PubMed ID: 33292236
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma.
Cheng J; Zhang R; Yan M; Li Y
BMC Cancer; 2022 Mar; 22(1):238. PubMed ID: 35241028
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of Long Non-Coding RNA
Zhan Y; Abuduwaili K; Wang X; Shen Y; Nuerlan S; Liu C
Cancer Manag Res; 2020; 12():7725-7737. PubMed ID: 32943921
[TBL] [Abstract][Full Text] [Related]
15. Exosome-derived lnc-HOXB8-1:2 induces tumor-associated macrophage infiltration to promote neuroendocrine differentiated colorectal cancer progression by sponging hsa-miR-6825-5p.
Li X; Lan Q; Lai W; Wu H; Xu H; Fang K; Chu Z; Zeng Y
BMC Cancer; 2022 Aug; 22(1):928. PubMed ID: 36030223
[TBL] [Abstract][Full Text] [Related]
16. LncRNA WDFY3-AS2 promotes cisplatin resistance and the cancer stem cell in ovarian cancer by regulating hsa-miR-139-5p/SDC4 axis.
Wu Y; Wang T; Xia L; Zhang M
Cancer Cell Int; 2021 May; 21(1):284. PubMed ID: 34051810
[TBL] [Abstract][Full Text] [Related]
17. CircIFFO1 suppresses tumor growth and metastasis of cutaneous squamous cell carcinoma by targeting the miR-424-5p/NFIB axis.
Yu H; Liu P; Chen T
Arch Dermatol Res; 2023 Nov; 315(9):2585-2596. PubMed ID: 37405427
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA SNHG1 contributes to cisplatin resistance in non-small cell lung cancer by regulating miR-140-5p/Wnt/β-catenin pathway.
Shi SL; Zhang ZH
Neoplasma; 2019 Sep; 66(5):756-765. PubMed ID: 31288529
[TBL] [Abstract][Full Text] [Related]
19. Circ_0000260 Regulates the Development and Deterioration of Gastric Adenocarcinoma with Cisplatin Resistance by Upregulating MMP11 via Targeting MiR-129-5p.
Liu S; Wu M; Peng M
Cancer Manag Res; 2020; 12():10505-10519. PubMed ID: 33122949
[TBL] [Abstract][Full Text] [Related]
20. LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis.
Wang P; Chen D; Ma H; Li Y
Onco Targets Ther; 2017; 10():5137-5149. PubMed ID: 29123412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
